Objectives HIV/hepatitis C virus (HCV) co-infection leads to major complications, and noninvasive markers developed to stage liver fibrosis could be used as prognostic markers. We aimed to compare the performances of liver stiffness (LS), fibrosis-4 (FIB-4), and aspartate aminotransferase to platelet ratio index (APRI) to predict liver-related...
-
2019 (v1)Journal articleUploaded on: December 4, 2022
-
September 15, 2016 (v1)Journal article
BACKGROUND:Human immunodeficiency virus (HIV)/hepatitis C virus (HCV)-coinfected patients with cirrhosis have long been considered to be difficult to treat, and real-life efficacy and tolerance data with all-oral direct-acting antiviral (DAA) combinations in these patients are scarce.METHODS:Cirrhotic HIV/HCV-coinfected patients enrolled in the...
Uploaded on: December 4, 2022 -
2018 (v1)Journal article
Compared to the general population, HIV-infected patients are at higher risk of developing non-AIDS-defining cancers. Chronic HCV infection has also been associated with a higher risk than that of the general population of developing cancers other than hepatocarcinoma. Evaluation of the impact of HCV-related factors on non-AIDS-defining and non...
Uploaded on: December 4, 2022 -
2017 (v1)Journal article
No description
Uploaded on: December 3, 2022 -
September 3, 2021 (v1)Journal article
Background: An increased risk of cardiovascular disease (CVD) was reported in patients coinfected with human immunodeficiency virus (HIV) and hepatitis C virus (HCV), without identifying factors associated with atherosclerotic CVD (ASCVD) events.Methods: HIV-HCV coinfected patients were enrolled in the Agence Nationale de Recherches sur le Sida...
Uploaded on: December 4, 2022